E-LIB Suche - Ergebnisse für: Oya, Shuki

1

High-dose cytarabine plus gemtuzumab ozogamicin as consolid..:

Oya, Shuki ; Ozawa, Hidetoshi ; Morishige, Satoshi...
International Journal of Hematology. , 2024

2

CRISPR/Cas9 gene editing clarifies the role of CD33 SNP rs1..:

Oya, Shuki ; Ozawa, Hidetoshi ; Nakamura, Takayuki...
International Journal of Hematology. 120 (2024) 2 - p. 194-202 , 2024

Link: https://doi.org/10.1007/..

3

Correlation of ex vivo and in vivo ammonia production with ..:

Nakamura, Takayuki ; Oya, Shuki ; Ozawa, Hidetoshi...
International Journal of Hematology. 119 (2024) 4 - p. 426-431 , 2024

Link: https://doi.org/10.1007/..

4

Alternating venetoclax/azacytidine and FLT3 inhibitor treat..:

Oya, Shuki ; Ozawa, Hidetoshi ; Maehiro, Yoshimi...
Leukemia Research. 130 (2023) - p. 107313 , 2023

Link: https://doi.org/10.1016/..

5

P473: CRISPR/CAS9 GENE EDITING CLARIFIES THE ROLE OF CD33 S..:

Oya, Shuki ; Ozawa, Hidetoshi ; Nakamura, Takayuki...
HemaSphere. 7 (2023) S3 - p. e53072ea , 2023

Link: https://doi.org/10.1097/..

6

Severe drug-induced immune hemolytic anemia due to cefmetaz..:

Fukuda, Masafumi ; Nabeta, Masakazu ; Oya, Shuki.
Int. Journal of Clinical Pharmacology and Therapeutics. 60 (2022) 1 - p. 52-56 , 2022

Link: https://doi.org/10.5414/..

7

A case of lymphomatoid granulomatosis with central nervous ..:

Yamasaki, Yoshitaka ; Morishige, Satoshi ; Komaki, Satoru...
International Journal of Hematology. 114 (2021) 4 - p. 502-508 , 2021

Link: https://doi.org/10.1007/..

8

Risks of Muscle Atrophy in Patients with Malignant Lymphoma..:

HIROTA, Keisuke ; MATSUSE, Hiroo ; KOYA, Shunji...
Physical Therapy Research. 24 (2021) 1 - p. 69-76 , 2021

Link: https://doi.org/10.1298/..

9

Successful correction of factor V deficiency of patient‐der..:

Nakamura, Takayuki ; Morishige, Satoshi ; Ozawa, Hidetoshi...
Haemophilia. 26 (2020) 5 - p. 826-833 , 2020

Link: https://doi.org/10.1111/..

10

Beneficial tyrosine kinase inhibitor therapy in a patient w..:

Oya, Shuki ; Morishige, Satoshi ; Ozawa, Hidetoshi...
International Journal of Hematology. 113 (2020) 2 - p. 285-289 , 2020

Link: https://doi.org/10.1007/..

11

Complete response following toxic epidermal necrolysis in r..:

Morishige, Satoshi ; Nishi, Marina ; Saruta, Hiroshi...
International Journal of Hematology. 110 (2019) 4 - p. 506-511 , 2019

Link: https://doi.org/10.1007/..

12

Breakthrough infection of Geotrichum capitatum during empir..:

Oya, Shuki ; Muta, Tsuyoshi
International Journal of Hematology. 108 (2018) 5 - p. 558-563 , 2018

Link: https://doi.org/10.1007/..

13

P473: CRISPR/CAS9 GENE EDITING CLARIFIES THE ROLE OF CD33 S..:

Oya, Shuki ; Ozawa, Hidetoshi ; Nakamura, Takayuki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429479/. , 2023

Link: http://www.ncbi.nlm.nih...

14

Risks of Muscle Atrophy in Patients with Malignant Lymphoma..:

HIROTA, Keisuke ; MATSUSE, Hiroo ; KOYA, Shunji...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111411/. , 2020

Link: http://www.ncbi.nlm.nih...

15

P473: CRISPR/CAS9 GENE EDITING CLARIFIES THE ROLE OF CD33 S..:

Shuki Oya ; Hidetoshi Ozawa ; Takayuki Nakamura...
http://journals.lww.com/10.1097/01.HS9.0000968800.53072.ea. , 2023

Link: https://doi.org/10.1097/..